Validating the nociceptin receptor for treating craving and withdrawal-associated affect in cocaine addiction pharmacotherapy
Ended Cooperative Agreement Awarded Last action
- Award ID
- U18DA052559
- Recipient
-
Astraea Therapeutics LLC UEI ZNNQAFC5FXH3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $229,620
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $229,620 |
Quick answers
Who received award U18DA052559?
U18DA052559 was awarded to Astraea Therapeutics LLC by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2020.
How much is award U18DA052559 worth?
$229,620 has been obligated on U18DA052559.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award